Aldactone (spironolactone)
Title: Aldactone (spironolactone)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 9/23/2016 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 23, 2016 Category: Cardiology Source Type: news
Aldactone (Spironolactone) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 8, 2016 Category: Drugs & Pharmacology Source Type: news
Mixed Results for Beet-Juice Effects on Arterial Function, Heart StructureMixed Results for Beet-Juice Effects on Arterial Function, Heart Structure
A small study showed signs that consuming inorganic nitrates in beetroot juice, with or without spironolactone, may improve cardiac remodeling. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 22, 2016 Category: Cardiology Tags: Cardiology News Source Type: news
Spironolactone in Patients With HF With Preserved EFSpironolactone in Patients With HF With Preserved EF
Does the efficacy of spironolactone in heart failure with preserved ejection fraction vary by LVEF amount? European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 22, 2016 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Hidden in plain sight: Well-known drug could yield new treatment for herpes viruses
(University of Utah Health Sciences) In a search for new antiviral drugs, University of Utah scientists found that a common heart failure medicine, spironolactone, has an unexpected ability to block Epstein Barr virus (EBV). The drug blocks a key step in viral infection common to all herpesviruses, revealing that it could be developed into a new class of drug to treat infections caused by herpesviruses including herpes, shingles, and mono. The research was published in PNAS. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 14, 2016 Category: Infectious Diseases Source Type: news
The Biggest Medical Stories You May Have Missed In 2015
SPECIAL FROM Next Avenue By Craig Bowron As we head into the New Year, let’s take a look back and see what lessons we should have learned from medical science in 2015. The New England Journal of Medicine’s publication Journal Watch provides physicians and other health care providers with expert analysis of the most recent medical research. Below is a brief synopsis of what the Journal Watch editors felt were the most important stories in general medicine for the year 2015. While you likely heard about a couple, others probably escaped your radar. Getting Aggressive with Strokes We’re familiar with the...
Source: Science - The Huffington Post - January 15, 2016 Category: Science Source Type: news
What Women Can Do About Hair Loss
SPECIAL FROM Next Avenue By Sheryl Kraft Everyone loses hair. In fact, it’s normal to lose between 50 and 100 hairs a day, according to the American Academy of Dermatology. But what if it seems like there’s significantly more loss than that? “Once you exceed that, you’re losing it at an abnormal rate,” says Dr. David J. Wong, clinical associate professor of dermatology at Stanford University. Contrary to popular notion, hair loss is not just a condition that men face: up to 40 percent of women in America also experience it. No ‘Bald Is Beautiful’ for Women Bruce Willis, Patri...
Source: Healthy Living - The Huffington Post - October 20, 2015 Category: Consumer Health News Source Type: news
Spironolactone Effective for Resistant Hypertension (FREE)
By Kelly Young
Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
Spironolactone is an effective add-on treatment for resistant hypertension, according to a Lancet study.Researchers studied over 300 people with a seated clinic systolic … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 22, 2015 Category: Primary Care Source Type: news
Persistent high blood pressure could be cured by Spironolactone
Spironolactone was first used in 1959 as a water pill to treat fluid retention - but a new British Heart Foundation study found it also works in three out of five patients whose blood pressure is out of control. (Source: the Mail online | Health)
Source: the Mail online | Health - September 2, 2015 Category: Consumer Health News Source Type: news
Spironolactone Effectively Lowers BP in Resistant HypertensionSpironolactone Effectively Lowers BP in Resistant Hypertension
Patients with resistant hypertension, those taking three drugs at maximally tolerated doses but still not at goal, should not be called "resistant" until they have tried spironolactone, according to PATHWAY2 researchers. Heartwire from Medscape (Source: theHeart.org)
Source: theHeart.org - August 31, 2015 Category: Cardiology Tags: Cardiology News Source Type: news
Spironolactone: The 'Other' Hormonal Acne Therapy
(MedPage Today) -- Expert: drug is effective and its safety issues can be managed (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 29, 2015 Category: Dermatology Source Type: news
Blood test for patients on acne medication deemed unnecessary
For young, healthy women taking spironolactone to treat hormonal acne, frequent office visits and blood draws are an unnecessary health care expense, researchers report. For the approximately 1,000 patients studied, blood tests to monitor potassium levels did not change the course of treatment, but the tests cumulatively totaled up to $80,000. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 23, 2015 Category: Science Source Type: news
Young Women Taking Spironolactone for Acne Don't Have Increased Rate of Hyperkalemia (FREE)
By Kelly Young
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
Regular potassium monitoring may not be required in young women prescribed spironolactone for acne, according to a study in JAMA Dermatology that was presented at the … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 23, 2015 Category: Primary Care Source Type: news
No increased rate of hyperkalemia in healthy women taking spironolactone for acne
Young women taking spironolactone for hormonally mediated acne do not need to be monitored for hyperkalemia, say the authors of a study that showed no significant increase in the risk of the condition.
The retrospective study in 974 otherwise healthy women taking spironolactone found the rate of... (Source: Skin and Allergy News)
Source: Skin and Allergy News - March 22, 2015 Category: Dermatology Tags: CME-candidate SAN Acne & Rosacea SAN Journals SAN Clinical News SAN News IMN Journals FPN Journals Source Type: news
Blood test for patients on acne medication deemed unnecessary
(Brigham and Women's Hospital) A new study by researchers at Brigham and Women's Hospital has found that for young, healthy women taking spironolactone to treat hormonal acne, frequent office visits and blood draws are an unnecessary health care expense. For the approximately 1,000 patients studied, blood tests to monitor potassium levels did not change the course of treatment, but the tests cumulatively totaled up to $80,000. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 22, 2015 Category: Global & Universal Source Type: news
